MSI1 and cancer: Although studies have shown that targeting MSI1 inhibits cancer growth (Lan et al., 2015), drugging the protein to inhibit its function in cancers remains a challenge as RNA-binding proteins are not enzymes, which have traditional catalytic pockets for inhibition.